| Name | Southwestern Eye Center Dme |
|---|---|
| Organization Name | Southwestern Eye Center, Ltd |
| Location | 2149 W 24th St, Yuma, Arizona 85364 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (928) 726-4120 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.
JuvoLab, a company focused on value creation in the life sciences industry, today announced the release of a unique study detailing the entire global oncology community's utilization of Twitter to enhance scientific discussion at the ASCO 2010 Annual Meeting. This pioneering study analyzed over 4450 tweets, generated by more than 680 users over the course of the conference, and provides clarity and insight into the use of Twitter from breaking clinical news and engaging in clinical discussion to compliant corporate promotion by industry leaders.
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that results from a United States Pharmacopeia Preservative Efficacy Test (USP PET) qualified NexACT as an anti-microbial preservative. The results show that NexACT was effective in killing more than 23 strains of bacteria, fungus and mold, well beyond the requirements for passing the USP PET.
Today, the International and American Associations for Dental Research (IADR/AADR) published a study titled "Enhancing Oral Health via Sense of Coherence: a Cluster Randomized Trial." This study by lead author Orawan Nammontri, University of Sheffield, UK, is published in the IADR/AADR Journal of Dental Research.
› Verified 4 days ago
| NPI Number | 1124343140 |
| Organization Name | SOUTHWESTERN EYE CENTER LTD |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2149 W 24th St, Yuma, AZ 85364 |
| Phone Number | 928-726-4120 |
News Archive
Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.
JuvoLab, a company focused on value creation in the life sciences industry, today announced the release of a unique study detailing the entire global oncology community's utilization of Twitter to enhance scientific discussion at the ASCO 2010 Annual Meeting. This pioneering study analyzed over 4450 tweets, generated by more than 680 users over the course of the conference, and provides clarity and insight into the use of Twitter from breaking clinical news and engaging in clinical discussion to compliant corporate promotion by industry leaders.
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that results from a United States Pharmacopeia Preservative Efficacy Test (USP PET) qualified NexACT as an anti-microbial preservative. The results show that NexACT was effective in killing more than 23 strains of bacteria, fungus and mold, well beyond the requirements for passing the USP PET.
Today, the International and American Associations for Dental Research (IADR/AADR) published a study titled "Enhancing Oral Health via Sense of Coherence: a Cluster Randomized Trial." This study by lead author Orawan Nammontri, University of Sheffield, UK, is published in the IADR/AADR Journal of Dental Research.
› Verified 4 days ago
News Archive
Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the European Respiratory Society (ERS) Annual Congress September 18 - 22, 2010 in Barcelona, Spain.
JuvoLab, a company focused on value creation in the life sciences industry, today announced the release of a unique study detailing the entire global oncology community's utilization of Twitter to enhance scientific discussion at the ASCO 2010 Annual Meeting. This pioneering study analyzed over 4450 tweets, generated by more than 680 users over the course of the conference, and provides clarity and insight into the use of Twitter from breaking clinical news and engaging in clinical discussion to compliant corporate promotion by industry leaders.
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that results from a United States Pharmacopeia Preservative Efficacy Test (USP PET) qualified NexACT as an anti-microbial preservative. The results show that NexACT was effective in killing more than 23 strains of bacteria, fungus and mold, well beyond the requirements for passing the USP PET.
Today, the International and American Associations for Dental Research (IADR/AADR) published a study titled "Enhancing Oral Health via Sense of Coherence: a Cluster Randomized Trial." This study by lead author Orawan Nammontri, University of Sheffield, UK, is published in the IADR/AADR Journal of Dental Research.
› Verified 4 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2577 S Avenue 2 1/2 E, Yuma, Arizona 85365 Phone: (928) 782-6509 | |
Rx Positive Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1845w 25th St, Yuma, Arizona 85364 Phone: (928) 344-9301 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1103 E 21st St, Yuma, Arizona 85365 Phone: (928) 783-4120 | |
German Dobson, Cvs Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11464s Fortuna Rd, Yuma, Arizona 85367 Phone: (928) 342-3433 | |
Cvs Pharmacy #09334 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2800 S 4th Ave, Yuma, Arizona 85364 Phone: (928) 344-2341 |